Department of Medicine, Lincoln Medical Center, New York, NY, USA.
Cebu Institute of Medicine, Cebu City, Philippines.
Expert Rev Cardiovasc Ther. 2024 Apr-May;22(4-5):193-200. doi: 10.1080/14779072.2024.2329720. Epub 2024 Mar 12.
Sex differences in clinical outcomes following acute myocardial infarction (AMI) are well known. However, data on sex differences among patients with familial hypercholesterolemia (FH) are limited. We aimed to explore sex differences in outcomes of AMI among patients with FH from a national administrative dataset.
We utilized the National Inpatient Sample to identify admissions with a primary diagnosis of AMI and a secondary diagnosis of FH. Our primary outcome of interest was in-hospital mortality; secondary outcomes were performance of percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), respiratory complications, use of inotropes, use of mechanical circulatory support (MCS), bleeding complications, transfusion and facility discharge. We adjusted for demographics (model A), comorbidities (model B), and intervention (model C).
Between October 2016 and December 2020, 5,714,993 admissions with a primary diagnosis of AMI were identified, of which 3,035 (0.05%) had a secondary diagnosis of FH. In-hospital mortality did not differ between men and women (Model C, adjusted OR = 0.85; 95% CI 0.28-2.60, = 0.773). There was no sex difference in the secondary outcomes.
Despite generally being older and having more comorbidities, women with FH fair equally with men with FH in terms of mortality during AMI admission.
急性心肌梗死(AMI)后临床结局的性别差异是众所周知的。然而,家族性高胆固醇血症(FH)患者的性别差异数据有限。我们旨在从国家行政数据集探索 FH 患者 AMI 结局的性别差异。
我们利用国家住院患者样本确定了主要诊断为 AMI 且次要诊断为 FH 的住院患者。我们感兴趣的主要结局是院内死亡率;次要结局是经皮冠状动脉介入治疗(PCI)、冠状动脉旁路移植术(CABG)、呼吸并发症、使用正性肌力药、使用机械循环支持(MCS)、出血并发症、输血和出院机构。我们调整了人口统计学因素(模型 A)、合并症(模型 B)和干预措施(模型 C)。
2016 年 10 月至 2020 年 12 月期间,确定了 5714993 例主要诊断为 AMI 的住院患者,其中 3035 例(0.05%)有 FH 的次要诊断。男性和女性之间的院内死亡率无差异(模型 C,调整后的 OR=0.85;95%CI 0.28-2.60,P=0.773)。次要结局无性别差异。
尽管 FH 女性通常年龄更大且合并症更多,但在 AMI 住院期间,她们的死亡率与 FH 男性相当。